Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)
China
· Delayed Price · Currency is CNY 29.55
-0.62 (-2.06%)
At close: Mar 9, 2026
Shanghai Rightongene Biotechnology Company Description
Shanghai Rightongene Biotechnology Co., Ltd. engages in the research and development, production, and sale of molecular diagnosis of infectious diseases in China.
The company offers self-operated reagents, purchased preparations, scientific research services, and testing services for blood diseases, solid tumors, infectious diseases and lymphoma.
Shanghai Rightongene Biotechnology Co., Ltd. was founded in 2012 and is based in Shanghai, China.
Shanghai Rightongene Biotechnology Co., Ltd.
| Country | China |
| Founded | 2012 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 385 |
| CEO | Shangxian Gao |
Contact Details
Address: No. 147, Lane 1817 Shanghai, 201403 China | |
| Phone | 86 21 3328 2601 |
| Website | rightongene.com |
Stock Details
| Ticker Symbol | 688217 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Shangxian Gao | Acting Chairman and GM |
| Hui Xiong | Chairman and GM |
| Chengli Zhang | Deputy General Manager |
| Liqun Xie | Deputy General Manager |
| Zhong He Ke | R&D Director and Director |